TheJobsMapAbout Wugen
Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.
Founded in 2018 by Matthew Cooper.
- Founded
- 2018
- Employees
- 125
- Total funding
- $172M
- Headquarters
- St. Louis
Leadership
The top of Wugen's org chart, with how many people report into each leader.
Kumar Srinivasan
President & CEO
41 reports
Ayman Kabakibi
COO & EVP, R&D
21 reports
Matthew Cooper
Chief Scientific Officer
8 reports
Keith Vendola
Chief Financial Officer
3 reports
Cherry T. Thomas
Chief Medical Officer
3 reports
Jim Faulkner
Chief Technology Officer
1 report
Board
Todd Fehniger
Advisor
Katharine Hsu
Advisor
Jeffrey Miller,
Advisor
Bali Muralidhar
Director
Bosun Hau
Board Director | Lead Investor
Waseem Qasim
Advisor
Jobs at Wugen
No open positions right now. Explore more companies on TheJobsMap.